Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3β/β-Catenin Signaling Pathway

Recent Advances in Anti-Survivin Treatments for Cancer

(2010) R. Kanwar et al.   CURRENT MEDICINAL CHEMISTRY

Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/ -Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth

(2009) N. Baryawno et al.   CANCER RESEARCH

Rosiglitazone Reduces the Development and Rupture of Experimental Aortic Aneurysms

(2009) Alun Jones et al.   CIRCULATION

Potential Therapeutic Effect of Glycogen Synthase Kinase 3  Inhibition against Human Glioblastoma

(2009) K. Miyashita et al.   CLINICAL CANCER RESEARCH

Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies

(2009) Nikhil G Thaker et al.   Expert Review of Neurotherapeutics

Glycogen synthase kinases-3β controls differentiation of malignant glioma cells

(2009) Yan Li et al.   INTERNATIONAL JOURNAL OF CANCER

Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas

(2009) Gangadhara Reddy Sareddy et al.   NEUROCHEMISTRY INTERNATIONAL

GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma

(2009) Serdar Korur et al.   PLoS One

Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth

(2008) P Pu et al.   CANCER GENE THERAPY

Mcl-1: A Gateway to TRAIL Sensitization

(2008) S.-H. Kim et al.   CANCER RESEARCH

Mcl-1 is a potential therapeutic target in multiple types of cancer

(2008) C. Akgul   CELLULAR AND MOLECULAR LIFE SCIENCES

Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer

(2008) Gordon Shore et al.   CURRENT MOLECULAR MEDICINE

Combination therapy for malignant glioma based on PTEN status

(2008) Javier Gonzalez et al.   Expert Review of Anticancer Therapy

Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3

(2008) Michal O. Nowicki et al.   NEURO-ONCOLOGY